TY - JOUR
T1 - Reappraisal of Peritoneal Washing Cytology in 984 Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Margin-Negative Resection
AU - Satoi, Sohei
AU - Murakami, Yoshiaki
AU - Motoi, Fuyuhiko
AU - Uemura, Kenichiro
AU - Kawai, Manabu
AU - Kurata, Masanao
AU - Sho, Masayuki
AU - Matsumoto, Ippei
AU - Yanagimoto, Hiroaki
AU - Yamamoto, Tomohisa
AU - Mizuma, Masamichi
AU - Unno, Michiaki
AU - Hashimoto, Yasushi
AU - Hirono, Seiko
AU - Yamaue, Hiroki
AU - Honda, Goro
AU - Nagai, Minako
AU - Nakajima, Yoshiyuki
AU - Shinzeki, Makoto
AU - Fukumoto, Takumi
AU - Kwon, A. Hon
N1 - Publisher Copyright:
© 2014, The Society for Surgery of the Alimentary Tract.
PY - 2014/1
Y1 - 2014/1
N2 - Results: Significant correlations between CY+ and high CA19-9 level, pancreatic body and tail cancer, lymph node metastasis, and a lower frequency of R0 resection were observed. Overall survival (OS) of CY+ patients was significantly worse than that of CY− patients (median survival time [MST], 16 vs. 25 months; 3-year OS rate, 6 vs. 37 %; p < 0.001). CY+ patients had a significantly higher rate of post-operative peritoneal carcinomatosis than CY− patients (48 vs. 21 %; p < 0.001). Administration of adjuvant chemotherapy did not provide a favorable survival outcome to CY+ patients. The current study showed that patients with M1 disease had acceptable MST after margin-negative resection and a high incidence of peritoneal carcinomatosis within 3 years after surgery, resulting in decreased long-term survival. The development of a new strategy to control peritoneal carcinomatosis when surgical resection is performed in such patients is required.Objective: The objective of the present study was to reappraise the clinical value of peritoneal washing cytology (CY) in 984 pancreatic ductal adenocarcinoma patients who underwent margin-negative resection.Methods: In a 2001–2011 database from seven high-volume surgical institutions in Japan, 69 patients (7 %) had positive CY (CY+ group) indicative of M1 disease and 915 patients had negative CY (CY− group). Clinicopathological data and survival were compared between groups.
AB - Results: Significant correlations between CY+ and high CA19-9 level, pancreatic body and tail cancer, lymph node metastasis, and a lower frequency of R0 resection were observed. Overall survival (OS) of CY+ patients was significantly worse than that of CY− patients (median survival time [MST], 16 vs. 25 months; 3-year OS rate, 6 vs. 37 %; p < 0.001). CY+ patients had a significantly higher rate of post-operative peritoneal carcinomatosis than CY− patients (48 vs. 21 %; p < 0.001). Administration of adjuvant chemotherapy did not provide a favorable survival outcome to CY+ patients. The current study showed that patients with M1 disease had acceptable MST after margin-negative resection and a high incidence of peritoneal carcinomatosis within 3 years after surgery, resulting in decreased long-term survival. The development of a new strategy to control peritoneal carcinomatosis when surgical resection is performed in such patients is required.Objective: The objective of the present study was to reappraise the clinical value of peritoneal washing cytology (CY) in 984 pancreatic ductal adenocarcinoma patients who underwent margin-negative resection.Methods: In a 2001–2011 database from seven high-volume surgical institutions in Japan, 69 patients (7 %) had positive CY (CY+ group) indicative of M1 disease and 915 patients had negative CY (CY− group). Clinicopathological data and survival were compared between groups.
KW - Adjuvant chemotherapy
KW - Pancreatic ductal adenocarcinoma
KW - Peritoneal carcinomatosis
KW - Peritoneal washing cytology
KW - Survival analysis
UR - http://www.scopus.com/inward/record.url?scp=84920613018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920613018&partnerID=8YFLogxK
U2 - 10.1007/s11605-014-2637-7
DO - 10.1007/s11605-014-2637-7
M3 - Article
C2 - 25316482
AN - SCOPUS:84920613018
SN - 1091-255X
VL - 19
SP - 6
EP - 14
JO - Journal of Gastrointestinal Surgery
JF - Journal of Gastrointestinal Surgery
IS - 1
ER -